<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article169</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index_gpt.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/OSCILLATE" style="display:block; margin-bottom:10px;">OSCILLATE Original</a></li>
<h2><strong>OSCILLATE</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "High-Frequency Oscillation in Early Acute Respiratory Distress Syndrome"<br/>
The New England Journal of Medicine, 2013.<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
Does early application of high-frequency oscillatory ventilation (HFOV) reduce mortality compared to a conventional low tidal volume and high PEEP ventilation strategy in adults with moderate-to-severe acute respiratory distress syndrome (ARDS)?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
In adults with moderate-to-severe ARDS, early application of HFOV does not improve, and may increase, in-hospital mortality compared to a conventional ventilation strategy of low tidal volume and high PEEP.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/>
<hr/><br/>
<h2><strong>Guidelines at the time of study publication did not explicitly address the early use of HFOV in patients with ARDS.</strong></h2><br/>
<br/>
<h2><strong>Design</strong></h2><br/>
- Multicenter, randomized, controlled trial<br/>
- N=548 adults with new-onset, moderate-to-severe ARDS<br/>
- Intervention: HFOV (n=275)<br/>
- Control: Conventional ventilation with low tidal volumes and high PEEP (n=273)<br/>
- Primary outcome: Rate of in-hospital death from any cause<br/>
- Randomization stopped early on the recommendation of the data monitoring committee<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
- Adult patients with new-onset, moderate-to-severe ARDS<br/>
- Inclusion criteria: Onset of pulmonary symptoms within past 2 weeks, intubation, hypoxemia, and bilateral air-space opacities on chest radiography<br/>
- Exclusion criteria included patients at risk for intracranial hypertension and other conditions limiting the duration of mechanical ventilation<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
- HFOV group received median of 3 days of HFOV.<br/>
- Control group received conventional ventilation with the use of low tidal volumes and high PEEP.<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
- In-hospital mortality: 47% in the HFOV group, 35% in the control group (relative risk of death with HFOV, 1.33; P=0.005).<br/>
- Patients in HFOV group received higher doses of midazolam and more frequent use of neuromuscular blockers and vasoactive drugs.<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
- Trial stopped early, which may overestimate the effect size.<br/>
- Alternative HFOV protocols that use different mean airway pressures or oscillatory frequencies were not tested.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
- Funded by the Canadian Institutes of Health Research and the King Abdullah International Medical Research Center.<br/>
- CareFusion loaned HFOV ventilators and provided technical support but had no role in other aspects of the trial.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
- Supplementary information and a list of investigators are available at NEJM.org.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
